secwatch.observer — SEC 8-K summary
======================================

Issuer:     ILLUMINA, INC. (ILMN)
CIK:        0001110803
Form:       8-K
Filed at:   2024-11-04T23:59:59+00:00
Accession:  0001110803-24-000049
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Illumina Q3 Core revenue $1.08B (-2% YoY); raises FY24 non-GAAP EPS guide to $4.05-$4.15
--------------------------------------------------------------------------------

- Core Illumina revenue $1.08B, down 2% YoY; GAAP diluted EPS $4.03, non-GAAP $1.14.
- Lowered FY2024 Core revenue guidance to ~3% decline; Q4 revenue expected ~$1.07B.
- Raised FY2024 non-GAAP operating margin guidance to 21%-21.5% and non-GAAP diluted EPS to $4.05-$4.15.
- Free cash flow $284M in Q3, up from $94M YoY; cash & short-term investments $939M.
- Introduced MiSeq i100 Series, FDA approval for TSO Comprehensive, GRAIL spin-off completed June 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1110803/000111080324000049/0001110803-24-000049-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1110803/000111080324000049/ilmn-20241104.htm
  HTML page:      https://secwatch.observer/filing/0001110803-24-000049

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer